CatalystPit

APREAprea Therapeutics, Inc.

NASDAQ · Pharmaceutical Preparations
Last close $0.75 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryPharmaceutical Preparations
Market cap$9.44M
RECENT INSIDER TRADES
  • 2026-06-17 · Duey Marc (Director) · OTHER
  • 2026-06-17 · Seizinger Bernd R. (Director) · OTHER
  • 2026-06-17 · Pamukcu Rifat (Director) · OTHER
  • 2026-06-17 · Gruia Gabriela (Director) · OTHER
  • 2026-06-17 · BIZZARI JEAN-PIERRE (Director) · OTHER
INSTITUTIONAL OWNERSHIP
Institutional holders29
Shares held2,437,399
Value$1.99M
Percent of shares outstanding19.36%
As of quarter end2026-06-30
RECENT NEWS
  • Aprea Therapeutics to Present at October Conferences
  • Aprea to present Phase 1 data on WEE1 inhibitor APR-1051
  • Aprea Therapeutics lifts outlook on early data at H.C. Wainwright conference
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
Aprea Therapeutics, Inc. (APRE) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit